ProfileGDS4718 / 216303_s_at
TitleColorectal cancer: homogenized tumor tissues
OrganismHomo sapiens


no metastasis metastatic recurrence metastasis stage: 0 stage: 1 stage: 2a stage: 2b stage: 3b stage: 3c stage: 2a stage: 2b stage: 3b stage: 3c stage: 4 GSM549121 GSM549102 GSM549104 GSM549108 GSM549119 GSM549133 GSM549139 GSM549099 GSM549109 GSM549110 GSM549114 GSM549122 GSM549134 GSM549136 GSM549140 GSM549111 GSM549113 GSM549132 GSM549137 GSM549142 GSM549100 GSM549107 GSM549115 GSM549116 GSM549120 GSM549131 GSM549118 GSM549129 GSM549123 GSM549124 GSM549126 GSM549128 GSM549103 GSM549117 GSM549138 GSM549141 GSM549130 GSM549101 GSM549105 GSM549106 GSM549112 GSM549125 GSM549127 GSM549135 32% 34% 32% 33% 34% 34% 31% 37% 36% 39% 41% 34% 36% 32% 25% 37% 37% 30% 24% 28% 36% 34% 39% 29% 27% 26% 30% 27% 37% 31% 32% 25% 36% 37% 32% 32% 30% 40% 32% 28% 37% 33% 29% 41% sort by disease state sort by other Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM549121patient 080, normal, homogenized [OPG study]4.6510832
GSM549102patient 115, normal, homogenized [OPG study]4.7240734
GSM549104patient 119, normal, homogenized [OPG study]4.593432
GSM549108patient 138, normal, homogenized [OPG study]4.7030533
GSM549119patient 077, normal, homogenized [OPG study]4.7343634
GSM549133patient 032, cancer, homogenized [OPG study]4.6458934
GSM549139patient 042, cancer, homogenized [OPG study]4.5691931
GSM549099patient 107, normal, homogenized [OPG study]4.86337
GSM549109patient 139, normal, homogenized [OPG study]4.8310736
GSM549110patient 046, normal, homogenized [OPG study]4.9282939
GSM549114patient 063, normal, homogenized [OPG study]5.0197141
GSM549122patient 082, normal, homogenized [OPG study]4.7301834
GSM549134patient 033, cancer, homogenized [OPG study]4.7836136
GSM549136patient 036, cancer, homogenized [OPG study]4.5831232
GSM549140patient 044, cancer, homogenized [OPG study]4.3082925
GSM549111patient 047, normal, homogenized [OPG study]4.8265637
GSM549113patient 057, normal, homogenized [OPG study]4.8061837
GSM549132patient 031, cancer, homogenized [OPG study]4.5218530
GSM549137patient 038, cancer, homogenized [OPG study]4.2805924
GSM549142patient 047, cancer, homogenized [OPG study]4.5898828
GSM549100patient 110, normal, homogenized [OPG study]4.8109436
GSM549107patient 135, normal, homogenized [OPG study]4.6662234
GSM549115patient 068, normal, homogenized [OPG study]4.8631339
GSM549116patient 072, normal, homogenized [OPG study]4.4641129
GSM549120patient 078, normal, homogenized [OPG study]4.4303227
GSM549131patient 030, cancer, homogenized [OPG study]4.3438926
GSM549118patient 074, normal, homogenized [OPG study]4.5593930
GSM549129patient 027, cancer, homogenized [OPG study]4.4298727
GSM549123patient 088, normal, homogenized [OPG study]4.8082237
GSM549124patient 006, cancer, homogenized [OPG study]4.6056631
GSM549126patient 015, cancer, homogenized [OPG study]4.6062732
GSM549128patient 025, cancer, homogenized [OPG study]4.3136825
GSM549103patient 117, normal, homogenized [OPG study]4.8521336
GSM549117patient 073, normal, homogenized [OPG study]4.7977437
GSM549138patient 041, cancer, homogenized [OPG study]4.5991132
GSM549141patient 045, cancer, homogenized [OPG study]4.5844132
GSM549130patient 028, cancer, homogenized [OPG study]4.5499130
GSM549101patient 111, normal, homogenized [OPG study]5.0217440
GSM549105patient 128, normal, homogenized [OPG study]4.6380532
GSM549106patient 134, normal, homogenized [OPG study]4.4274328
GSM549112patient 048, normal, homogenized [OPG study]4.8523637
GSM549125patient 011, cancer, homogenized [OPG study]4.6954933
GSM549127patient 024, cancer, homogenized [OPG study]4.5000529
GSM549135patient 035, cancer, homogenized [OPG study]4.9745941